miR-135a promotes gastric cancer progression and resistance to oxaliplatin

Resistance to oxaliplatin (OXA)-based chemotherapy regimens continues to be a major cause of gastric cancer (GC) recurrence and metastasis. We analyzed GC samples and matched non-tumorous control stomach tissues from 280 patients and found that miR-135a was overexpressed in GC samples relative to co...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Lin-Hai, Chen, Zhi-Ning, Li-Li, Chen, Jia, Wei, Wen-E, Mo, Xian-Wei, Qin, Yu-Zhou, Lin, Yuan, Chen, Jian-Si
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342584/
https://www.ncbi.nlm.nih.gov/pubmed/27683111
http://dx.doi.org/10.18632/oncotarget.12208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342584/
https://www.ncbi.nlm.nih.gov/pubmed/27683111
http://dx.doi.org/10.18632/oncotarget.12208

Ejemplares similares